Showing results (21-30 of 34) with videos related to
Sort By:
Pageof 4
European Urology|August 14, 2022
Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder CancerAlberto Gil-Jimenez, Jeroen van Dorp, Alberto Contreras-Sanz, et al.Science Translational Medicine|October 11, 2019
Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patientsSalo N Ooft, Fleur Weeber, Krijn K Dijkstra, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2024
Platinum-Based Chemotherapy Induces Opposing Effects on Immunotherapy Response-Related Spatial and Stromal Biomarkers in the Bladder Cancer MicroenvironmentMaksim A Chelushkin, Jeroen van Dorp, Sandra van Wilpe, et al.Nature Medicine|May 6, 2016
Facilitating a culture of responsible and effective sharing of cancer genome dataLillian L Siu, Mark Lawler, David Haussler, et al.Nature|February 24, 2022
Effective drug combinations in breast, colon and pancreatic cancer cellsPatricia Jaaks, Elizabeth A Coker, Daniel J Vis, et al.European Journal of Cancer (Oxford, England : 1990)|September 11, 2025
Final clinical analysis of pre-operative ipilimumab and nivolumab in locally advanced urothelial cancer and exploration of tumor-draining lymph node composition: The NABUCCO trialChantal F Stockem, Jeroen van Dorp, Nick van Dijk, et al.Nature Communications|June 17, 2026
Tremelimumab with or without durvalumab in combination with paclitaxel in metastatic urothelial cancer: phase I/II ICRA trialSarah M H Einerhand, Hamza Ali, Stephen Q Wong, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 9, 2025
Biomarker Analysis and Treatment Dynamics Following Preoperative Ipilimumab plus Nivolumab in Locally Advanced Urothelial Cancer from the Phase IB NABUCCO StudyChantal F Stockem, Alberto Gil-Jimenez, Hamza Ali, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2021
Ovarian Cancer-Specific <i>BRCA</i>-like Copy-Number Aberration Classifiers Detect Mutations Associated with Homologous Recombination Deficiency in the AGO-TR1 TrialPhilip C Schouten, Lisa Richters, Daniel J Vis, et al.Nature Medicine|February 27, 2026
Ipilimumab and nivolumab followed by chemoradiotherapy as bladder-sparing treatment in muscle-invasive bladder cancer: a phase 2 trialJan-Jaap J Mellema, Chantal F Stockem, Cameron Herberts, et al.Pageof 4